(Q83532358)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

24 January 2020

main subject

1 reference

Xiaoxia Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Hui Sun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Shengxiang Ren

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Vikramsingh Kim Curran

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Ling Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Songwen Zhou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Jie Zhang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Caicun Zhou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

207-213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22374424%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12094-012-0785-3

24 January 2020

exact match

0 references

cites work

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer

1 reference

12 December 2020

Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.

1 reference

12 December 2020

Pharmacogenetics in gastrointestinal tumors

1 reference

12 December 2020

A haplotype map of the human genome

1 reference

12 December 2020

DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study

1 reference

12 December 2020

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

1 reference

12 December 2020

Cancer statistics, 2009

1 reference

12 December 2020

DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population

1 reference

12 December 2020

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

1 reference

12 December 2020

Recent progress in carcinogenesis, progression and therapy of lung cancer: the 19th Hiroshima Cancer Seminar: the 3rd Three Universities' Consortium International Symposium, November 2009.

1 reference

12 December 2020

Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes

1 reference

12 December 2020

Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

1 reference

12 December 2020

Analysis of epidemiological cohort data on smoking effects and lung cancer with a multi-stage cancer model

1 reference

12 December 2020

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.

1 reference

12 December 2020

An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer.

1 reference

12 December 2020

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

1 reference

12 December 2020

Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.

1 reference

12 December 2020

Predicting drug response and toxicity based on gene polymorphisms

1 reference

12 December 2020

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.

1 reference

12 December 2020

Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.

1 reference

12 December 2020

Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

1 reference

12 December 2020

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

1 reference

12 December 2020

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

12 December 2020

Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer

1 reference

12 December 2020

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

1 reference

12 December 2020

Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.

1 reference

12 December 2020

Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.

1 reference

12 December 2020